^
    4years
    Phase I Clinical Study of HWH340 Tablet in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=85, Recruiting, Hubei Biological Medicine Industrial Technology Institute Co., Ltd. | N=45 --> 85 | Trial completion date: Jun 2019 --> Sep 2021 | Trial primary completion date: Jun 2019 --> Mar 2021
    Clinical • Enrollment change • Trial completion date • Trial primary completion date • BRCA Biomarker
    |
    HER-2 (Human epidermal growth factor receptor 2) • BRCA1 (Breast cancer 1, early onset) • BRCA2 (Breast cancer 2, early onset) • BRCA (Breast cancer early onset)
    |
    BRCA2 mutation • BRCA1 mutation • BRCA mutation
    |
    HWH340